rs5253

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000085.5(CLCNKB):​c.1685T>C​(p.Met562Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.96 in 1,613,870 control chromosomes in the GnomAD database, including 747,019 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 61143 hom., cov: 32)
Exomes 𝑓: 0.97 ( 685876 hom. )

Consequence

CLCNKB
NM_000085.5 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.34

Publications

34 publications found
Variant links:
Genes affected
CLCNKB (HGNC:2027): (chloride voltage-gated channel Kb) The protein encoded by this gene is a member of the family of voltage-gated chloride channels. Chloride channels have several functions, including the regulation of cell volume, membrane potential stabilization, signal transduction and transepithelial transport. This gene is expressed predominantly in the kidney and may be important for renal salt reabsorption. Mutations in this gene are associated with autosomal recessive Bartter syndrome type 3 (BS3). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
CLCNKB Gene-Disease associations (from GenCC):
  • Bartter disease type 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • Bartter disease type 4B
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Gitelman syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000085.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.2137257E-7).
BP6
Variant 1-16053701-T-C is Benign according to our data. Variant chr1-16053701-T-C is described in ClinVar as Benign. ClinVar VariationId is 447094.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.979 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000085.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLCNKB
NM_000085.5
MANE Select
c.1685T>Cp.Met562Thr
missense
Exon 16 of 20NP_000076.2P51801-1
CLCNKB
NM_001165945.2
c.1178T>Cp.Met393Thr
missense
Exon 9 of 13NP_001159417.2P51801-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLCNKB
ENST00000375679.9
TSL:1 MANE Select
c.1685T>Cp.Met562Thr
missense
Exon 16 of 20ENSP00000364831.5P51801-1
CLCNKB
ENST00000906263.1
c.1739T>Cp.Met580Thr
missense
Exon 17 of 21ENSP00000576322.1
CLCNKB
ENST00000906270.1
c.1739T>Cp.Met580Thr
missense
Exon 17 of 21ENSP00000576329.1

Frequencies

GnomAD3 genomes
AF:
0.888
AC:
134991
AN:
152028
Hom.:
61122
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.696
Gnomad AMI
AF:
0.997
Gnomad AMR
AF:
0.929
Gnomad ASJ
AF:
0.947
Gnomad EAS
AF:
0.820
Gnomad SAS
AF:
0.919
Gnomad FIN
AF:
0.939
Gnomad MID
AF:
0.962
Gnomad NFE
AF:
0.985
Gnomad OTH
AF:
0.911
GnomAD2 exomes
AF:
0.935
AC:
234686
AN:
251092
AF XY:
0.941
show subpopulations
Gnomad AFR exome
AF:
0.686
Gnomad AMR exome
AF:
0.948
Gnomad ASJ exome
AF:
0.952
Gnomad EAS exome
AF:
0.808
Gnomad FIN exome
AF:
0.938
Gnomad NFE exome
AF:
0.984
Gnomad OTH exome
AF:
0.953
GnomAD4 exome
AF:
0.967
AC:
1413473
AN:
1461724
Hom.:
685876
Cov.:
69
AF XY:
0.967
AC XY:
703266
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.679
AC:
22731
AN:
33480
American (AMR)
AF:
0.943
AC:
42157
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.953
AC:
24899
AN:
26136
East Asian (EAS)
AF:
0.818
AC:
32479
AN:
39700
South Asian (SAS)
AF:
0.932
AC:
80408
AN:
86252
European-Finnish (FIN)
AF:
0.936
AC:
49863
AN:
53270
Middle Eastern (MID)
AF:
0.968
AC:
5585
AN:
5768
European-Non Finnish (NFE)
AF:
0.988
AC:
1098270
AN:
1112006
Other (OTH)
AF:
0.945
AC:
57081
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2568
5137
7705
10274
12842
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21624
43248
64872
86496
108120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.888
AC:
135058
AN:
152146
Hom.:
61143
Cov.:
32
AF XY:
0.885
AC XY:
65849
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.696
AC:
28864
AN:
41474
American (AMR)
AF:
0.928
AC:
14199
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.947
AC:
3287
AN:
3472
East Asian (EAS)
AF:
0.820
AC:
4232
AN:
5164
South Asian (SAS)
AF:
0.919
AC:
4430
AN:
4818
European-Finnish (FIN)
AF:
0.939
AC:
9959
AN:
10602
Middle Eastern (MID)
AF:
0.959
AC:
282
AN:
294
European-Non Finnish (NFE)
AF:
0.985
AC:
66976
AN:
68002
Other (OTH)
AF:
0.910
AC:
1920
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
636
1273
1909
2546
3182
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
894
1788
2682
3576
4470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.957
Hom.:
92580
Bravo
AF:
0.877
Asia WGS
AF:
0.817
AC:
2840
AN:
3478
EpiCase
AF:
0.984
EpiControl
AF:
0.986

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
3
not provided (3)
-
-
1
Bartter disease type 3 (1)
-
-
1
Bartter disease type 4B (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
0.017
DANN
Benign
0.53
DEOGEN2
Benign
0.23
T
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.0025
N
LIST_S2
Benign
0.015
T
MetaRNN
Benign
8.2e-7
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.94
N
PhyloP100
-1.3
PROVEAN
Benign
0.22
N
REVEL
Benign
0.28
Sift
Benign
0.87
T
Sift4G
Benign
0.70
T
Varity_R
0.049
gMVP
0.34
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5253;
hg19: chr1-16380196;
COSMIC: COSV107483759;
COSMIC: COSV107483759;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.